Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u prethodnih 30 dana:11
  • preuzimanja u prethodnih 30 dana:7
članak: 1 od 1  
Medicinski časopis
2018, vol. 52, br. 4, str. 134-139
jezik rada: engleski
vrsta rada: izvorni naučni članak
doi:10.5937/mckg52-19163


Procena istorije skrininga papa testa kod pacijenata sa karcinomom grlića materice u provinciji Isfahan tokom 2014-2016 godine
Isfahan University of Medical Sciences, School of Medicine, Community Medicine Department, Isfahan, Iran

e-adresa: negahtavakolifard@yahoo.com

Sažetak

Uvod. Odsustvo redovnog skrininga karcinoma grlića materice u Iranu i visoke stope dijagnostikovanog karcinoma u uznapredovalim stadijumima pokazuju važnost izvođenja skrininga. Stoga je cilj ove studije bio da se proceni istorija skrininga Papa testa kod pacijenata sa karcinomom grlića materice u provinciji Isfahan tokom 2014-2016 godine. Metode. U ovoj deskriptivno-analitičkoj studiji, 77 pacijenata sa karcinomom grlića materice je izabrano u provinciji Isfahan. Podaci su izdvojeni iz medicinske dokumentacije. Za analizu podataka korišćeni su Kruskal-Wallisov test, jednosmerna analiza, Chi-Square, Mann-Whithney, T test i Pearsonov test. Rezultati. U trenutnoj studiji, 38,9% pacijenata sa karcinomom grlića materice nije obavilo Papa test tokom svog života. Štaviše, 38.09% je obavilo skrining u period koji je kraći od 3 godine od postavljanja dijagnoze a 19.48% u period dužem od 3 godine. Postojala je značajna relacija između skrininga i starosti pri dijagnozi, broja trudnoća i starosti u trenutku prvog seksualnog odnosa (p<0,01). Statistička analiza je pokazala da je nivo obrazovanja bio veći kod pacijenata kod kojih je postavljena dijagnoza u period kraćem od 3 godine nego kod onih sa dijagnozom u period dužem od 3 godine (p=0,04). Učestalost pacijenata koji su vršili skrining u gradskoj zoni bila je značajno veća od ruralne (p= 0,048). Štaviše, uočena je značajna razlika između vrste provajdera usluga skrininga u smislu lokacije (p= 0,03). Zaključak. Rezultat ove studije ukazuje na ulogu uticajnih faktora na Papa test skriningu. Štaviše, istorija nečinjenja Papa testa u našoj zemlji u odnosu na druge zemlje je visoka što dovodi do odložene dijagnoze. Stoga je neophodan opšti program skrininga za poboljšanje svesti stanovništva u tom pogledu.

Ključne reči

Reference

Naknadno pridodat članak: provera, normiranje i linkovanje referenci u toku.
Behnamfar F, Azadehrah M. Factors associated with delayed diagnosis of cervical cancer in Iran - a survey in Isfahan City. Asian Pac J Cancer Prev 2015; 16:635-9.
Spence AR, Alobaid A, Drouin P, et al. Screening histories and contact with physicians as determinants of cervical cancer risk in Montreal, Quebec. Curr Oncol 2014; 21:294-304.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.
Khorasanizadeh F, Hassanloo J, Khaksar N, et al. Epidemiology of cervical cancer and human papilloma virus infection among Iranian women - analyses of national data and systematic review of the literature. Gynecol Oncol 2013; 128:277-81.
Devi BC, Tang TS, Corbex M. Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Ann Oncol 2007; 18:1172-6.
Vinh-Hung V, Bourgain C, Vlastos G, et al. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer 2007; 7:164.
Thomson CS, Forman D. Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? Br J Cancer 2009; 101:102-9.
Nygård JF, Skare GB, Thoresen SØ. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. J Med Screen 2002; 9:86-91.
Othman NH, Devi BC, Halimah Y. Cervical cancer screening: patients understanding in major hospitals in Malaysia. Asian Pacific J Cancer Prev 2009; 10:569-74.
Shy K, Chu J, Mandelson M, Greer B, Figge D. Papanicolaou smear screening interval and risk of cervical cancer. Obstet Gynecol 1989; 74:838-43.
Massomi Z, Khani S, Gharosian M, Farhadian M, Shayan A. The prevalence of abnormal Pap smears in females referred to health centers affiliated to medical sciences during the Years 2012 to 2016. J Educ Community Health 2016; 3:16-22.
Allgar VL, Neal RD. Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer. Br J Cancer 2005; 92:1959-70.
Subramaniam A, Fauci JM, Schneider KE, et al. Invasive Cervical Cancer and screening: what are the rates of unscreened and underscreened women in the modern era? J Low Genit Tract Dis 2011; 15:110-3.
Darlin L, Borgfeldt C, Widén E, Kannisto P. Elderly women above screening age diagnosed with cervical cancer have a worse prognosis. Anticancer Res 2014; 34:5147-51.
Ma J, Zhu Q, Han S, et al. Effect of socio-economic factors on delayed access to health care among Chinese cervical cancer patients with late rectal complications after radiotherapy. Gynecol Oncol 2012; 124:395-8.
WHO International Agency for Research on Cancer (IARC). Tobacco smoke and involuntary smoking. Lyon, France, 2004.
Louie KS, Castellsague X, de Sanjose S, et al (2011); International agency for research on cancer multicenter cervical cancer study group. Smoking and passive smoking in cervical cancer risk: pooled analysis of couples from the IARC multicentric casecontrol studies. Cancer Epidemiol Biomarkers Prev 2011; 20:1379-90.
Samet JM, Yoon S-Y. Gender, women, and the tobacco epidemic. Geneva, Switzerland: World Health Organization, 2010.
Eleje GU, Eke AC, Igberase GO, Igwegbe AO, Eleje LI. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer. Cochran Collaboration: John Wiley & Sons, Ltd, 2016.
Chen CS, Park S, Shin JH, et al. Endovascular treatment for the control of active vaginal bleeding from uterine cervical cancer treated with radiotherapy. Acta Radiol 2018; 59:1336-42.
Orwat J, Caputo N, Key W, De Sa J. Comparing rural and urban cervical and breast cancer screening rates in a privately insured population. Soc Work Public Health 2017; 32:311-23.
Horner-Johnson W, Dobbertin K, Jezzoni LI. Disparities in receipt of breast and cervical cancer screening for rural women age 18 to 64 with disabilities. Womens Health Issues 2015; 25:246-53.
Bishwajit G, Kpoghomou MA. Urban-rural differentials in the uptake of mammography and cervical cancer screening in Kenya. J Cancer Policy 2017; 12:43-8.